Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and...( Complimentary Continuing Education Mo...),Health

Complimentary Continuing Education Monograph for Healthcare Professionals

VOORHEES, N.J., June 29 /PRNewswire/ -- Hereditary angioedema (HAE) is an autosomal dominant disease affecting between 4,000 and 10,000 people in the United States. HAE causes recurrent attacks of intense localized edema involving the skin, airway, and visceral organs. While chronic therapy with attenuated androgens or plasmin inhibitors has been the mainstay of HAE therapy, many new therapies for prophylaxis and acute treatment are on the horizon. It is important for physicians to understand the diagnostic strategies in HAE as well as the conventional and emerging therapeutic options available for HAE prophylaxis and acute attacks.

To address the need for current education on HAE, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education monograph entitled Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment. The content for this monograph was derived from a live symposium which took place on February 13, 2009 in Fort Lauderdale, Florida. This activity is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians.

Faculty reviewers include Michael M. Frank, MD from Duke University School of Medicine in Durham, NC; Bruce L. Zuraw, MD from the University of California, San Diego School of Medicine in San Diego, CA; and Marc A. Riedl, MD from the University of California, Los Angeles David Geffen School of Medicine in Los Angeles, CA.

Physicians can visit http://www.rmei.com/HAE118 to download a copy of this monograph.

"Quality continuing medical education is vital to developing an
'/>"/>